Enumeral Biomedical Corp. — Form D

Enumeral Biomedical Corp. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2011-04-29. The offering totals $3.3M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Barry BucklandDirectorNew York, NY
Emanuele OstuniDirectorNew York, NY
John RydzewskiDirectorNew York, NY
Arthur TinkelenbergDirectorNew York, NY
Daniel WolfeDirectorNew York, NY
John RydzewskiExecutive OfficerNew York, NY
Arthur TinkelenbergExecutive OfficerNew York, NY
Michael J WeissDirectorNewark, NJ
Daniel B WolfeDirectorMontclair, NJ
John J RydzewskiDirectorCambridge, MA
John J RydzewskiExecutive OfficerCambridge, MA
Arthur H TinkelenbergDirectorCambridge, MA
Arthur H TinkelenbergExecutive OfficerCambridge, MA
Allan B RothsteinDirectorCambridge, MA
Emanuele H OstuniDirectorNew York, NY
Michael H WeissDirectorNew York, NY
Allan H RothsteinDirectorNew York, NY
Barry H BucklandDirectorNew York, NY
Derek H BrandExecutive OfficerNew York, NY
John H RydzewskiDirectorNew York, NY
John H RydzewskiExecutive OfficerNew York, NY
Daniel H WolfeDirectorNew York, NY
Derek B BrandExecutive OfficerNew York, NY
Michael B WeissDirectorNew York, NY
Daniel B. WolfeDirectorSalem, NH

Other filings by this issuer (4)

FiledFormOfferingSold
2014-05-07D$2.0M
2014-02-10D$750K$635K
2013-05-14D$1.5M
2012-07-09D$3.0M$2.3M

More